Operating Expenses

R&D

Linde R&D increased by 8.6% to $38.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $38.00M to $38.00M. Over 4 years (FY 2021 to FY 2025), R&D shows relatively stable performance with a 0.7% CAGR.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026

How to read this metric

Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.

Detailed definition

Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...

Peer comparison

Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.

Metric ID: research_and_development

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$34.00M$36.00M$38.00M$35.00M$37.00M$35.00M$36.00M$36.00M$35.00M$36.00M$39.00M$38.00M$36.00M$37.00M$39.00M$38.00M$38.00M$36.00M$35.00M$38.00M
QoQ Change+5.9%+5.6%-7.9%+5.7%-5.4%+2.9%+0.0%-2.8%+2.9%+8.3%-2.6%-5.3%+2.8%+5.4%-2.6%+0.0%-5.3%-2.8%+8.6%
YoY Change+8.8%-2.8%-5.3%+2.9%-5.4%+2.9%+8.3%+5.6%+2.9%+2.8%+0.0%+0.0%+5.6%-2.7%-10.3%+0.0%
Range$34.00M$39.00M
CAGR+2.4%
Avg YoY Growth+0.8%
Median YoY Growth+1.4%

Frequently Asked Questions

What is Linde's r&d?
Linde (LIN) reported r&d of $38.00M in Q1 2026.
How has Linde's r&d changed year-over-year?
Linde's r&d decreased by 0.0% year-over-year, from $38.00M to $38.00M.
What is the long-term trend for Linde's r&d?
Over 4 years (2021 to 2025), Linde's r&d has grown at a 0.7% compound annual growth rate (CAGR), from $143.00M to $147.00M.
What does r&d mean?
The money spent on creating new products or improving existing ones to drive future growth.